跳至主要内容
临床试验/IRCT20210530051441N2
IRCT20210530051441N2招募中3 期

The effect of myoinositol supplementation on serum levels of Pro-oxidant Antioxidant Balance (PAB), leptin and adiponectin, nutritional status and appetite in patients with non-alcoholic fatty liver disease

Qazvin University of Medical Sciences0 个研究点目标入组 42 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • Age 18-55 years
  • Body mass index = 30-40 Kg /m2
  • Willingness to cooperate
  • Hepatic steatosis based on Grade 1 and 2 NAFLD disease

排除标准

  • Athlete, pregnancy, lactation and menopause in women
  • Smoking and drinking alcohol
  • Adherence to a special diet or weight loss 3 months before the study
  • Use of chemical or herbal medicines for weight loss, hepatotoxic (phenytoin, amoxifine, lithium), lipid-lowering (statins), Insulin sensitizer, corticosteroids and non-steroidal, anti-inflammatory medications and any dietary supplements for 3 months before the study
  • History of weight loss surgery over the last year
  • those with cardiovascular, hepatic, renal, intestinal, thyroid and parathyroid dysfunction, billiary, any known autoimmune diseases, PCOs, cancers and conditions with mal-absorption such as Sprue and Crohn
  • Candidate or history of Liver transplant

研究者

相似试验